Mak Capital One LLC Autolus Therapeutics PLC Transaction History
Mak Capital One LLC
- $698 Million
- Q2 2025
A detailed history of Mak Capital One LLC transactions in Autolus Therapeutics PLC stock. As of the latest transaction made, Mak Capital One LLC holds 16,955,098 shares of AUTL stock, worth $36.5 Million. This represents 5.54% of its overall portfolio holdings.
Number of Shares
16,955,098Holding current value
$36.5 Million% of portfolio
5.54%Shares
1 transactions
Others Institutions Holding AUTL
# of Institutions
100Shares Held
165MCall Options Held
0Put Options Held
39.3K-
Wellington Management Group LLP Boston, MA27.1MShares$58.4 Million0.01% of portfolio
-
Blackstone Inc New York, NY20.5MShares$44 Million0.22% of portfolio
-
Deep Track Capital, LP Greenwich, CT16.9MShares$36.2 Million1.36% of portfolio
-
Syncona Portfolio LTD Guernsey, Channel Islands, X016.6MShares$35.8 Million98.24% of portfolio
-
Armistice Capital, LLC New York, NY12MShares$25.8 Million0.48% of portfolio
About Autolus Therapeutics plc
- Ticker AUTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 90,909,800
- Market Cap $195M
- Description
- Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...